RxDoctor Payments Data

Emanuel Shapera, MD

Surgical Oncology · Temecula, CANPI 1407268790

Payments from drug & device makers

What this record shows

This record is dominated by education: $19,500 of the $24,076 with a category attached, or 81.0%. Intuitive Surgical accounts for 87.9% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2023 at $12,666 and has fallen 91.6% since, to $1,066 in 2025. Among surgical oncology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$24,076in general payments, 2019–2025

Across 63 payments — averaging $382.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$21K
  • Histosonics, Inc.$897
  • Angiodynamics, Inc.$520
  • Enterra Medical, Inc.$208
  • Biom'up France SAS$182
  • Johnson & Johnson$179
  • plus $918 from 12 others

What the payments were for

  • Travel & lodging$2,0649%
  • Food & beverage$2,51310%
  • Education$19,50081%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,076 in reported general payments places this provider in the 90th percentile of 209 surgical oncology providers in California.

See all surgical oncology providers in California

Medicare billing

Part B allowed, 2024
$101,795
Medicare patients
145
Services billed
340

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl28$164

Paid to pharmacies, not to this prescriber.

Other surgical oncology in Temecula

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →